Mastodon

Levomikon-TFF (Ointment) Instructions for Use

Marketing Authorization Holder

Tula Pharmaceutical Factory, LLC (Russia)

ATC Code

D06C (Antibiotics and chemotherapeutic agents in combination with other drugs)

Active Substances

Chloramphenicol (Rec.INN WHO registered)

Dioxomethyltetrahydropyrimidine (Grouping name)

Dosage Form

Bottle OTC Icon Levomikon-TFF Ointment for external use: jars or tubes 20 g, 25 g, 30 g, 40 g, 50 g, 60 g, 70 g, 80 g, or 100 g

Dosage Form, Packaging, and Composition

Ointment for external use white or white with a yellowish tint.

100 g
Dioxomethyltetrahydropyrimidine (methyluracil) 4 g
Chloramphenicol 0.75 g

Excipients: macrogol 1500 – 19.05 g, macrogol 400 – 76.2 g.

20 g – jars (1) – cardboard packs.
25 g – jars (1) – cardboard packs.
30 g – jars (1) – cardboard packs.
40 g – jars (1) – cardboard packs.
50 g – jars (1) – cardboard packs.
60 g – jars (1) – cardboard packs.
70 g – jars (1) – cardboard packs.
80 g – jars (1) – cardboard packs.
100 g – jars (1) – cardboard packs.
20 g – tubes (1) – cardboard packs.
25 g – tubes (1) – cardboard packs.
30 g – tubes (1) – cardboard packs.
40 g – tubes (1) – cardboard packs.
50 g – tubes (1) – cardboard packs.
60 g – tubes (1) – cardboard packs.
70 g – tubes (1) – cardboard packs.
80 g – tubes (1) – cardboard packs.
100 g – tubes (1) – cardboard packs.

Clinical-Pharmacological Group

A drug with antibacterial and tissue regeneration-improving action for external use

Pharmacotherapeutic Group

Antibiotics and antimicrobial agents used in dermatology; antibiotics for topical use; other antibiotics for topical use

Pharmacological Action

A combined medicinal product for topical use, it has anti-inflammatory (dehydrating) and antimicrobial action, and is active against gram-positive and gram-negative microorganisms (staphylococci, Pseudomonas aeruginosa, and Escherichia coli).

It easily penetrates deep into tissues without damaging biological membranes and stimulates regeneration processes.

The antibacterial action is preserved in the presence of pus and necrotic masses. Dioxomethyltetrahydropyrimidine, by normalizing nucleic acid metabolism, stimulates regeneration processes in wounds, tissue growth and granulation maturation, epithelialization, and has an anti-inflammatory (dehydrating) effect.

Indications

Purulent wounds (including those infected with mixed microflora) in the first (purulent-necrotic) phase of the wound process.

ICD codes

ICD-10 code Indication
T79.3 Posttraumatic wound infection, not elsewhere classified
ICD-11 code Indication
NF0A.3 Posttraumatic wound infection, not elsewhere classified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Apply the ointment topically only.

Use sterile gauze napkins impregnated with the ointment to loosely fill the wound cavity.

Alternatively, introduce the ointment into purulent cavities through a catheter or drainage tube using a syringe.

Apply the dressing once daily or as directed by a physician based on the severity of the wound process.

Change the dressing more frequently if copious exudate causes it to become heavily saturated.

Prior to each application, cleanse the wound surface from residual ointment, pus, and necrotic tissue.

The duration of treatment is determined by the rate of wound cleansing, appearance of granulations, and onset of epithelialization.

Discontinue use and consult a physician if signs of local irritation or allergic reaction develop.

For extensive wounds or prolonged courses of therapy, monitor hematological parameters via clinical blood tests.

Adverse Reactions

Allergic reactions skin rashes.

Contraindications

Children under 1 year of age (in newborns, the biotransformation of chloramphenicol occurs more slowly than in adults); hypersensitivity to the components of the combination.

With caution

Pregnancy, lactation (breastfeeding).

Use in Pregnancy and Lactation

Use during pregnancy is possible if the benefit to the mother outweighs the risk to the fetus.

During lactation, either the use of the medicinal product should be discontinued or breastfeeding should be stopped.

Pediatric Use

Use is contraindicated in children under 1 year of age (in newborns, the biotransformation of chloramphenicol occurs more slowly than in adults).

Special Precautions

When applied to large areas of the skin and during long courses of treatment, a clinical blood test should be performed.

Storage Conditions

Store at 2°C (36°F) to 15°C (59°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS